Eugene McCloskey
University of Sheffield · Sheffield University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eugene McCloskey as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:31 UTC. Open this list on ClinicalTrials.gov
- N/ANCT01430858 · Does Vibration Therapy Induce Higher Than Normal Bone Strains and Strain Rates Than Those Experienced During Habitual Daily ActivitiesSheffield Teaching Hospitals NHS Foundation Trust · completed · Osteoporosis · principal investigator
- Ph4NCT01293292 · Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of ActionSheffield Teaching Hospitals NHS Foundation Trust · completed · Osteoporosis · principal investigator
- Ph2NCT00666627 · Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential EffectsSheffield Teaching Hospitals NHS Foundation Trust · completed · Post-menopausal Osteoporosis · study director
- N/ANCT00666640 · 3D Imaging of the Hip Using DXASheffield Teaching Hospitals NHS Foundation Trust · completed · Osteoporosis, Low-energy Trauma Fracture · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:31 UTC. The ranking covers the 200 most relevant of 67 PubMed records, and a shared surname and initials can bring in a namesake. All 67 on PubMed
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.J Clin Oncol · 1993431 citationsRCR 13.5
- 300 citationsRCR 18.6
- Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.J Clin Oncol · 2002268 citationsRCR 5.5
- A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults.Br J Haematol · 1998248 citationsRCR 7.0
- Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.J Bone Miner Res · 2008219 citationsRCR 6.7
- Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial.Lancet · 2018219 citationsRCR 11.1
- Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.J Bone Miner Res · 1997215 citationsRCR 6.3
- Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].Breast Cancer Res · 2006207 citationsRCR 4.7
- Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis.J Clin Endocrinol Metab · 2008194 citationsRCR 5.9
- A high incidence of vertebral fracture in women with breast cancer.Br J Cancer · 1999192 citationsRCR 5.1